US09077V1008
© Globe Newswire
04.12.2025
BIOA
LISTED
NASDAQ
BioAge Announces Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
News Preview
BGE-102 was well-tolerated in SAD and initial MAD cohorts, with a pharmacokinetic profile supporting once-daily oral dosing...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.11.2025
BIOA
LISTED
NASDAQ
BioAge Labs to Present at Piper Sandler 37th Annual Healthcare Conference
News Preview
EMERYVILLE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Piper Sandler 37th Annual Healthcare...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2025
BIOA
LISTED
NASDAQ
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
News Preview
EMERYVILLE, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Jefferies Global Healthcare Conferen...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
06.11.2025
BIOA
LISTED
NASDAQ
BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates
News Preview
First participant dosed in Phase 1 trial of BGE-102, oral CNS-penetrant NLRP3 inhibitor, with initial SAD data expected by year-end...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
20.08.2025
BIOA
LISTED
NASDAQ
BioAge Labs to Present at Upcoming Investor Conferences
News Preview
EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conf...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.08.2025
BIOA
LISTED
NASDAQ
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
News Preview
First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.06.2025
BIOA
LISTED
NASDAQ
BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions
News Preview
Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.05.2025
BIOA
LISTED
NASDAQ
BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates
News Preview
RICHMOND, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging, today provided business updates and reported its first quarter 2025 financial results....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.03.2025
BIOA
LISTED
NASDAQ
BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024
News Preview
Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected 2H25...
Themefolio
Profiler
Peergroup
© BusinessWire
10.03.2025
BIOA
LISTED
NASDAQ
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against BioAge Labs, Inc. (“BioAge” or “the Company”) (NASDAQ: BIOA) for violations of the federal securities laws.
Investors who purchased the Company's securities pursuant and/or traceable to the Company’s initial public offer...
Themefolio
Profiler
Peergroup
© BusinessWire
07.03.2025
BIOA
LISTED
NASDAQ
Deadline Soon: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
News Preview
The Law Offices of Frank R. Cruz reminds investors of the upcoming March 10, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) common stock pursuant and/or traceable to the Registration Statement issued...
Themefolio
Profiler
Peergroup
© BusinessWire
07.03.2025
BIOA
LISTED
NASDAQ
BIOA Deadline: Rosen Law Firm Urges BioAge Labs, Inc. (NASDAQ: BIOA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to BioAge’s initial public offering conducted on September 26, 2024 (the “IPO”). BioAge describes itself as a “clinical-stage biopharmaceutical c...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
26.02.2025
BIOA
LISTED
NASDAQ
BIOA INVESTOR ALERT: Kirby McInerney LLP Reminds BioAge Labs, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
News Preview
The law firm of Kirby McInerney LLP notifies investors of the approaching March 10, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ:BIOA) securities from September 22, 2024, through January 7, 2025 (“the Class Period”)...
Themefolio
Profiler
Peergroup
© BusinessWire
25.02.2025
BIOA
LISTED
NASDAQ
BIOA CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. Shareholders of Securities Fraud Class Action Lawsuit
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (NASDAQ: BIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or abou...
Themefolio
Profiler
Peergroup
© BusinessWire
19.02.2025
BIOA
LISTED
NASDAQ
Kirby McInerney LLP Urges Investors in BioAge Labs, Inc. (BIOA) to Inquire About Their Rights in Class Action Lawsuit
News Preview
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ:BIOA) securities during the period from September 22, 2024, through January 7, 2025 (“the Class Per...
Themefolio
Profiler
Peergroup
© BusinessWire
12.02.2025
BIOA
LISTED
NASDAQ
BIOA INVESTOR ALERT: Kirby McInerney LLP Notifies BioAge Labs, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
News Preview
The law firm of Kirby McInerney LLP reminds investors of the March 10, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ:BIOA) securities during the period from September 22, 2024, through January 7, 2025 (“the Class...
Themefolio
Profiler
Peergroup
© BusinessWire
20.01.2025
BIOA
LISTED
NASDAQ
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge” or “the Company”) (NASDAQ: BIOA) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged vio...
Themefolio
Profiler
Peergroup
© BusinessWire
15.01.2025
BIOA
LISTED
NASDAQ
Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming March 10, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) common stock pursuant and/or traceable to the Registration Statement issued in co...
Themefolio
Profiler
Peergroup
© BusinessWire
14.01.2025
BIOA
LISTED
NASDAQ
Deadline Approaching: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming March 10, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s Sep...
Themefolio
Profiler
Peergroup
© BusinessWire
14.01.2025
BIOA
LISTED
NASDAQ
BIOA Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against BioAge Labs, Inc.
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge”) (NASDAQ: BIOA) on behalf of those who purchased stock pursuant and/or traceable to BioAge's registration statement for its initial public offering (“IPO”) held on or abou...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2025
BIOA
LISTED
NASDAQ
Law Offices of Frank R. Cruz Encourages BioAge Labs, Inc. (BIOA) Investors to Inquire About Securities Fraud Class Action
News Preview
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s September 2024 initial public offering (the “IPO” or the...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2025
BIOA
LISTED
NASDAQ
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages BioAge Labs, Inc. (BIOA) Investors To Inquire About Securities Fraud Class Action
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) common stock pursuant and/or traceable to the Registration Statement issued in...
Themefolio
Profiler
Peergroup
© BusinessWire
13.01.2025
BIOA
LISTED
NASDAQ
BIOA INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of BioAge Labs, Inc. (NASDAQ: BIOA) stock pursuant and/or traceable to BioAge Labs’ registration statement issued in connection with BioAge Labs’ initial public offering (“IPO”) held on September 26, 2024, have until March 10, 2025 to seek appointment as lead plaintiff of...
Themefolio
Profiler
Peergroup
© BusinessWire
12.01.2025
BIOA
LISTED
NASDAQ
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge” or “the Company”) (NASDAQ: BIOA) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged vio...
Themefolio
Profiler
Peergroup
© BusinessWire
10.01.2025
BIOA
LISTED
NASDAQ
Law Offices of Howard G. Smith Encourages BioAge Labs, Inc. (BIOA) Investors To Inquire About Securities Fraud Class Action
News Preview
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) common stock pursuant and/or traceable to the Registration Statement issued in connection with the Company’s September, 2024 initial public offering (the “IPO” or the...
Themefolio
Profiler
Peergroup
© BusinessWire
10.01.2025
BIOA
LISTED
NASDAQ
BIOA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of BioAge Labs, Inc. (NASDAQ: BIOA) stock pursuant and/or traceable to BioAge Labs’ registration statement issued in connection with BioAge Labs’ initial public offering (“IPO”) held on September 26, 2024, have until March 10, 2025 to seek appointment as le...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2025
BIOA
LISTED
NASDAQ
BioAge Labs, Inc. (BIOA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BIOAGE LABS, INC. (BIOA), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2025
BIOA
LISTED
NASDAQ
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces the firm has filed a class action lawsuit against BioAge Labs, Inc. (“BioAge” or “the Company”) (NASDAQ: BIOA) for violations of the federal securities laws.
Investors who purchased the Company's securities pursuant and/or traceable to the Company’s initial public offe...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2025
BIOA
LISTED
NASDAQ
Securities Fraud Investigation Into BioAge Labs, Inc. (BIOA) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of (“BioAge” or the “Company”) (NASDAQ: BIOA) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BIOAGE LABS, INC. (BIOA), C...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2025
BIOA
LISTED
NASDAQ
Securities Fraud Investigation Into BioAge Labs, Inc. (BIOA) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON BIOAGE LABS, INC. CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2025
BIOA
LISTED
NASDAQ
Rosen Law Firm Urges BioAge Labs, Inc. (NASDAQ: BIOA) Stockholders to Contact the Firm for Information About Their Rights
News Preview
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to BioAge’s initial public offering conducted on September 26, 2024 (the “IPO”). BioAge describes itself as a “clinical-stage biopharmaceutical company t...
Themefolio
Profiler
Peergroup
© BusinessWire
10.12.2024
BIOA
LISTED
NASDAQ
BIOA Investors Have Opportunity to Join BioAge Labs, Inc. Securities Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of BioAge Labs, Inc. (“BioAge” or “the Company”) (NASDAQ: BIOA) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to dis...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
